Navigation Links
Vanda Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
Date:12/3/2013

WASHINGTON, Dec. 3, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will deliver a corporate presentation at the 25th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, December 4, 2013 at 11:30 a.m. Eastern Time.

The presentation at the Piper Jaffray Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page.  Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Vanda Pharmaceuticals to Present at the Lazard Healthcare Conference
2. Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
3. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
4. Vanda Pharmaceuticals Reports First Quarter 2013 Results
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
8. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
9. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
10. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
11. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... report to their offering. This report ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Asia-Pacific , and Rest of ... 2012 through 2020. Market data and analytics are derived from ...
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
(Date:8/18/2014)... Dallas, Texas (PRWEB) August 19, 2014 ... China Linalool Industry” is a professional and in-depth ... report provides basic Linalool information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... $40 Million ... , ... 18, 2010 -- DuPont announced plans to expand its cutting-edge plant genetics research to help ... in central Iowa with additional lab facilities and jobs focused on advanced plant genetics., , ...
... ... Voxel Tracker™ is first-of-its-kind , ... Pittsburgh, PA (Vocus) March 18, 2010 -- Celsense, Inc. ... The software, dubbed Voxel Tracker™, was designed to optimize the use of Celsense’ ...
... experimenters three years to believe, University of Michigan engineers ... twist ribbons of nanoparticles. The results are published ... Matter readily bends and twists light. That,s the mechanism ... the opposite interaction has rarely been observed, said Nicholas ...
Cached Biology Technology:DuPont to Expand Plant Genetics Research Facilities 2DuPont to Expand Plant Genetics Research Facilities 3Novel Imaging Software Released by Celsense Inc. 2Novel Imaging Software Released by Celsense Inc. 3Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3
(Date:8/19/2014)... students in college biology and other science courses ... quantitative ways, and now they have a new ... the Life Sciences," published this month by Princeton ... Institute for Mathematical and Biological Synthesis (NIMBioS), teaches ... can be used to explore and explain biological ...
(Date:8/19/2014)... of UTSA researchers has been awarded a nearly $40,000 ... Training (NCPTT), an office of the National Park Service ... will fund a one-year study of the energy efficiency ... homes in hot, humid climates. , Radiant barriers are ... that reflect heat back, thereby reducing the amount of ...
(Date:8/19/2014)... a number of ways. They have an impressive ability ... After being struck by lightning, for example, a tree ... one major downside to life as a plant: They ... they live and therefore completely at the mercy of ... developed mechanisms that enable them to rapidly adapt their ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3How steroid hormones enable plants to grow 2
... Surgical treatment for mitral valve disease includes either ... a metal, mechanical valve or an animal tissue valve. ... require a major incision in the chest. Now, after ... Medical Center in Baltimore conclude that minimally invasive mitral ...
... species in the Basque Country, and alternative to Pinus ... and Alonsotegui (Muro, 1975) where the eucalyptus, amongst other ... plantations such as those of eucalyptus came about in ... pulp industry. Blights and diseases arose as one of ...
... 28th, 2009 New prenatal tests for Down syndrome are soon ... States, yet telling an expectant couple that their child will ... physicians are trained for, claims research published in the ... decades of surveys and interviews, offers several recommendations for how ...
Cached Biology News:Study details safe, effective, minimally invasive mitral valve repair 2Study details safe, effective, minimally invasive mitral valve repair 3Canker disease in eucalyptus in the Basque Country 2Canker disease in eucalyptus in the Basque Country 3Canker disease in eucalyptus in the Basque Country 4How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 2How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 3
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
MDMA Mouse Monoclonal Antibody (Clone 3G8)...
Biology Products: